Skip to main content
TipRanks
Go Ultimate75% OFF

Allan Shaw Insider Profile

4 Followers

Allan Shaw, Director at CalciMedica, holds ― shares in CalciMedica (Ticker: CALC), holds 0.00 shares in Onconetix (Ticker: ONCO), holds 33.53K shares in Akari Therapeutics (Ticker: AKTX).

Allan Shaw's Trading History

ONCO
Onconetix
Aug 23, 2022DirectorInformative Sell116.77K$0.00
AKTX
Akari Therapeutics
Jan 02, 2015DirectorUninformative Buy―$247.12K
VVUSQ
Vivus
―――$747.51
CALC
CalciMedica
―Director――

You May Also Like

Allan Shaw insider profile FAQ

What is the percentage of profitable transactions made by Allan Shaw?
The percentage of profitable transactions made by Allan Shaw is 50%.
What is the average return per transaction made by Allan Shaw?
The average return per transaction made by Allan Shaw is 36.20%.
What stocks does Allan Shaw hold?
Allan Shaw holds: CALC, AKTX, ONCO, VVUSQ stocks.
What was Allan Shaw's most profitable transaction?
Allan Shaw’s most profitable transaction was an Informative Sell of ONCO stock on August 23, 2022. The return on the trade was 72.40%.
What is Allan Shaw's role in CalciMedica?
Allan Shaw's role in CalciMedica is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.